Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial

Marc Dewey, Matthias Rief, Peter Martus, Benjamin Kendziora, Sarah Feger, Henryk Dreger, Sascha Priem, Fabian Knebel, Marko Böhm, Peter Schlattmann, Bernd Hamm, Eva Schönenberger, Michael Laule, Elke Zimmermann, Marc Dewey, Matthias Rief, Peter Martus, Benjamin Kendziora, Sarah Feger, Henryk Dreger, Sascha Priem, Fabian Knebel, Marko Böhm, Peter Schlattmann, Bernd Hamm, Eva Schönenberger, Michael Laule, Elke Zimmermann

Abstract

Objective: To evaluate whether invasive coronary angiography or computed tomography (CT) should be performed in patients clinically referred for coronary angiography with an intermediate probability of coronary artery disease.

Design: Prospective randomised single centre trial.

Setting: University hospital in Germany.

Participants: 340 patients with suspected coronary artery disease and a clinical indication for coronary angiography on the basis of atypical angina or chest pain.

Interventions: 168 patients were randomised to CT and 172 to coronary angiography. After randomisation one patient declined CT and 10 patients declined coronary angiography, leaving 167 patients (88 women) and 162 patients (78 women) for analysis. Allocation could not be blinded, but blinded independent investigators assessed outcomes.

Main outcome measure: The primary outcome measure was major procedural complications within 48 hours of the last procedure related to CT or angiography.

Results: Cardiac CT reduced the need for coronary angiography from 100% to 14% (95% confidence interval 9% to 20%, P<0.001) and was associated with a significantly greater diagnostic yield from coronary angiography: 75% (53% to 90%) v 15% (10% to 22%), P<0.001. Major procedural complications were uncommon (0.3%) and similar across groups. Minor procedural complications were less common in the CT group than in the coronary angiography group: 3.6% (1% to 8%) v 10.5% (6% to 16%), P=0.014. CT shortened the median length of stay in the angiography group from 52.9 hours (interquartile range 49.5-76.4 hours) to 30.0 hours (3.5-77.3 hours, P<0.001). Overall median exposure to radiation was similar between the CT and angiography groups: 5.0 mSv (interquartile range 4.2-8.7 mSv) v 6.4 mSv (3.4-10.7 mSv), P=0.45. After a median follow-up of 3.3 years, major adverse cardiovascular events had occurred in seven of 167 patients in the CT group (4.2%) and six of 162 (3.7%) in the coronary angiography group (adjusted hazard ratio 0.90, 95% confidence interval 0.30 to 2.69, P=0.86). 79% of patients stated that they would prefer CT for subsequent testing. The study was conducted at a University hospital in Germany and thus the performance of CT may be different in routine clinical practice. The prevalence was lower than expected, resulting in an underpowered study for the predefined primary outcome.

Conclusions: CT increased the diagnostic yield and was a safe gatekeeper for coronary angiography with no increase in long term events. The length of stay was shortened by 22.9 hours with CT, and patients preferred non-invasive testing.Trial registration ClinicalTrials.gov NCT00844220.

Conflict of interest statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi-disclosure.pdf (available on request from the corresponding author) and declare that (1) MD has support from the Heisenberg programme of the German Research Foundation for the submitted work; (2) MD has relationships with Bayer, Bracco, Cardiac MR Academy, European Commission, European Regional Development Fund, German Foundation of Heart Research, German Federal Ministry of Education and Research, GE Healthcare, Guerbet, Springer, and Toshiba; BH has relationships with Bayer, Bracco, GE, Guerbet, Philips, Siemens, and Toshiba; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) have no non-financial interests that may be relevant to the submitted work. Institutional master research agreements exist with Siemens Medical Solutions, Philips Medical Systems, and Toshiba Medical Systems. The terms of these arrangements are managed by the legal department of Charité–Universitätsmedizin Berlin.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5076567/bin/dewm033661.f1_default.jpg
Fig 1 Flowchart of patients through the study. ECG=electrocardiography; MRI=magnetic resonance imaging; CT=computed tomography
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5076567/bin/dewm033661.f2_default.jpg
Fig 2 Length of stay and proportion of patients discharged. Computed tomography (CT) shortened median length of stay from 52.9 hours in coronary angiography group (interquartile range 49.5-76.4) to 30.0 hours (3.5-77.3, P<0.001). Because coronary angiography in Germany is mostly done after hospital admission, patients in our study were mostly in hospital. Of the 167 patients in the CT group, 64 (38%) were managed on an outpatient basis, 11 (7%) had outpatient CT but were admitted to hospital for suspected coronary artery disease, and 92 (55%) were randomised after hospital admission for clinically indicated coronary angiography
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5076567/bin/dewm033661.f3_default.jpg
Fig 3 Exposure to radiation in computed tomography (CT) and invasive coronary angiography group. Box plots of radiation dose in both groups are shown. Median overall radiation exposure, including invasive angiographies and revascularisations, was similar between the CT group (5.0 mSv; interquartile range 4.2-8.7) and coronary angiography group (6.4 mSv; 3.4-10.7, P=0.45). The dose for left ventriculography, which was done in 19 of the 24 patients who underwent coronary angiography in the CT group (79%) and in 141 of the 162 patients in the coronary angiography (87%), was included in the radiation exposure of the respective group
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5076567/bin/dewm033661.f4_default.jpg
Fig 4 Need for invasive coronary angiography over time. The rate of coronary angiographies was significantly lower per patient during the first six months after randomisation to the computed tomography (CT) group (A) compared with coronary angiography group (0.25 v 1.1; B, P<0.001). In the 6-12 months after randomisation, the proportion of patients undergoing coronary angiography was the same between the groups (P=0.74)

References

    1. Montalescot G, Sechtem U, Achenbach S, et al. Task Force Members ESC Committee for Practice Guidelines Document Reviewers. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003. 10.1093/eurheartj/eht296. .
    1. Patel MR, Peterson ED, Dai D, et alLow diagnostic yield of elective coronary angiography. N Engl J Med 2010;362:886-9510.1056/NEJMoa0907272.
    1. Moschovitis A, Cook S, Meier B. Percutaneous coronary interventions in Europe in 2006. EuroIntervention 2010;6:189-94. 10.4244/EIJV6I2A31.
    1. Noto TJ Jr, , Johnson LW, Krone R, et al. Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 1991;24:75-83. 10.1002/ccd.1810240202 .
    1. Levenson B, Albrecht A, Göhring S, et al. QuIK-Register des Bundesverbandes Niedergelassener Kardiologen (BNK). [6th report of the German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 2006–2009]. Herz 2011;36:41-9. 10.1007/s00059-011-3423-x. .
    1. Schuetz GM, Schlattmann P, Dewey M. Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies.BMJ 2012;345:e6717 10.1136/bmj.e6717. .
    1. Schlattmann P, Schuetz GM, Dewey M. Influence of coronary artery disease prevalence on predictive values of coronary CT angiography: a meta-regression analysis. Eur Radiol 2011;21:1904-13. 10.1007/s00330-011-2142-2 .
    1. Genders TS, Petersen SE, Pugliese F, et al. The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis. Ann Intern Med 2015;162:474-84. 10.7326/M14-0027. .
    1. Douglas PS, Hoffmann U, Patel MR, et al. PROMISE Investigators. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015;372:1291-300. 10.1056/NEJMoa1415516. .
    1. Newby DE, Fox KA, Flint LL, Boon NA. A ‘same day’ direct-access chest pain clinic: improved management and reduced hospitalization. QJM 1998;91:333-710.1093/qjmed/91.5.333.
    1. SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 2015;385:2383-91. 10.1016/S0140-6736(15)60291-4. .
    1. Lubbers M, Dedic A, Coenen A, et al. Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicentre, randomized CRESCENT trial. Eur Heart J 2016;37:1232-43. 10.1093/eurheartj/ehv700. .
    1. Schoenhagen P, Dewey M. CT assessment of coronary artery disease: trends and clinical implications. JACC Cardiovasc Imaging 2013;6:1072-4. 10.1016/j.jcmg.2013.07.006. .
    1. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869 10.1136/bmj.c869. .
    1. Schulz KF, Altman DG, Moher D, Group C. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332 10.1136/bmj.c332. .
    1. Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574-5. 10.1016/S0735-1097(83)80093-X .
    1. Pryor DB, Shaw L, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90. 10.7326/0003-4819-118-2-199301150-00001 .
    1. Dewey M, Rutsch W, Schnapauff D, Teige F, Hamm B. Coronary artery stenosis quantification using multislice computed tomography. Invest Radiol 2007;42:78-84. 10.1097/01.rli.0000251569.01317.60 .
    1. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23. 10.1148/radiology.218.1.r01ja50215. .
    1. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53. 10.1056/NEJM200011163432003. .
    1. Perk J, De Backer G, Gohlke H, et alEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635-701. 10.1093/eurheartj/ehs092.
    1. Chow BJ, Small G, Yam Y, et al. CONFIRM Investigators. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry. Arterioscler Thromb Vasc Biol 2015;35:981-9. 10.1161/ATVBAHA.114.304351. .
    1. Windecker S, Kolh P, Alfonso F, et al. Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619. 10.1093/eurheartj/ehu278. .
    1. Dewey M, Zimmermann E, Deissenrieder F, et al. Noninvasive Coronary Angiography by 320-Row CT with Lower Radiation Exposure and Maintained Diagnostic Accuracy: Comparison of Results with Cardiac Catheterization in a Head-To-Head Pilot Investigation. Circulation 2009;120:867-75. Circulation 2009;120: 867-75. 10.1161/CIRCULATIONAHA.109.859280 .
    1. Dewey M, Laule M, Krug L, et al. Multisegment and halfscan reconstruction of 16-slice computed tomography for detection of coronary artery stenoses. Invest Radiol 2004;39:223-9. 10.1097/01.rli.0000115201.27096.6e .
    1. Leschka S, Kim CH, Baumueller S, et al. Scan length adjustment of CT coronary angiography using the calcium scoring scan: effect on radiation dose. AJR Am J Roentgenol 2010;194:W272-7 10.2214/AJR.09.2970 .
    1. Zimmermann E, Dewey M. Whole-heart 320-row computed tomography: reduction of radiation dose via prior coronary calcium scanning. Rofo 2011;183:54-9. 10.1055/s-0029-1245629. .
    1. Gottlieb I, Miller JM, Arbab-Zadeh A, et al. The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 2010;55:627-34. 10.1016/j.jacc.2009.07.072 .
    1. Huda W, Ogden KM, Khorasani MR. Converting dose-length product to effective dose at CT. Radiology 2008;248:995-1003. 10.1148/radiol.2483071964 .
    1. Leung KC, Martin CJ. Effective doses for coronary angiography. Br J Radiol 1996;69:426-31. 10.1259/0007-1285-69-821-426 .
    1. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71. 10.1016/S0735-1097(86)80454-5 .
    1. Schönenberger E, Schnapauff D, Teige F, Laule M, Hamm B, Dewey M. Patient acceptance of noninvasive and invasive coronary angiography. PLoS One 2007;2:e246 10.1371/journal.pone.0000246 .
    1. Cox DR. Regression Models and Life-Tables. J R Stat Soc B 1972;34:187-220.
    1. Napp A, Haase R, Laule M, et al. Computed Tomography versus Invasive Coronary Angiography: Design and Methods of the Pragmatic Randomised Multicentre DISCHARGE Trial. Eur Radiol 2016; in press.
    1. Braunwald E. Unstable angina. A classification. Circulation 1989;80:410-4. 10.1161/01.CIR.80.2.410 .
    1. Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction Authors/Task Force Members Chairpersons Biomarker Subcommittee ECG Subcommittee Imaging Subcommittee Classification Subcommittee Intervention Subcommittee Trials & Registries Subcommittee Trials & Registries Subcommittee Trials & Registries Subcommittee Trials & Registries Subcommittee ESC Committee for Practice Guidelines (CPG) Document Reviewers. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98. 10.1016/j.jacc.2012.08.001. .
    1. Hurley R. Can doctors reduce harmful medical overuse worldwide?. BMJ 2014;349:g4289 10.1136/bmj.g4289. .
    1. Lenzer J. Choosing Wisely: setbacks and progress. BMJ 2015;351:h6760 10.1136/bmj.h6760. .
    1. Dewey M, Hamm B. Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease. Eur Radiol 2007;17:1301-9. 10.1007/s00330-006-0439-3. .
    1. Genders TS, Meijboom WB, Meijs MF, et alCT coronary angiography in patients suspected of having coronary artery disease: decision making from various perspectives in the face of uncertainty. Radiology 2009;253:734-44. 10.1148/radiol.2533090507.
    1. Hamilton-Craig C, Fifoot A, Hansen M, et al. Diagnostic performance and cost of CT angiography versus stress ECG--a randomized prospective study of suspected acute coronary syndrome chest pain in the emergency department (CT-COMPARE). Int J Cardiol 2014;177:867-73. 10.1016/j.ijcard.2014.10.090. .
    1. Winkens R, Dinant GJ. Evidence base of clinical diagnosis: Rational, cost effective use of investigations in clinical practice. BMJ 2002;324:783 10.1136/bmj.324.7340.783 .
    1. Agus AM, McKavanagh P, Lusk L, et al. The cost-effectiveness of cardiac computed tomography for patients with stable chest pain. Heart 2016;102:356-62. 10.1136/heartjnl-2015-308247. .
    1. Thom H, West NE, Hughes V, et al. CECaT study group. Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-term outcomes from the CECaT randomised controlled trial. BMJ Open 2014;4:e003419 10.1136/bmjopen-2013-003419. .
    1. Geleijns J, Dewey M. Physics Background and Radiation Exposure. In: Dewey M, ed. Cardiac CT.Springer, 2014;58 10.1007/978-3-642-41883-9_7
    1. Sox HC Jr, , Margulies I, Sox CH. Psychologically mediated effects of diagnostic tests. Ann Intern Med 1981;95:680-5. 10.7326/0003-4819-95-6-680 .
    1. Halliburton SS, Abbara S, Chen MY, et al. SCCT guidelines on radiation dose and radiation dose-optimization strategies in cardiovascular CT. J Cardiovasc Comput Tomogr 2011;5:198-224.
    1. Hoffmann U, Akers SR, Brown RK, et al. ACR Appropriateness Criteria Acute Nonspecific Chest Pain-Low Probability of Coronary Artery Disease. J Am Coll Radiol 2015;12(12 Pt A):1266-71. 10.1016/j.jacr.2015.09.004. .
    1. Taylor AJ, Cerqueira M, Hodgson JM, et al. American College of Cardiology Foundation Appropriate Use Criteria Task Force Society of Cardiovascular Computed Tomography American College of Radiology American Heart Association American Society of Echocardiography American Society of Nuclear Cardiology North American Society for Cardiovascular Imaging Society for Cardiovascular Angiography and Interventions Society for Cardiovascular Magnetic Resonance. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2010;56:1864-94. 10.1016/j.jacc.2010.07.005. .
    1. Maurer MH, Zimmermann E, Schlattmann P, Germershausen C, Hamm B, Dewey M. Indications, imaging technique, and reading of cardiac computed tomography: survey of clinical practice. Eur Radiol 2012;22:59-72. 10.1007/s00330-011-2239-7. .
    1. Chow BJ, Abraham A, Wells GA, et al. Diagnostic accuracy and impact of computed tomographic coronary angiography on utilization of invasive coronary angiography. Circ Cardiovasc Imaging 2009;2:16-23. 10.1161/CIRCIMAGING.108.792572. .
    1. Pugliese F, Hunink MG, Gruszczynska K, et al. Learning curve for coronary CT angiography: what constitutes sufficient training?. Radiology 2009;251:359-68. 10.1148/radiol.2512080384. .
    1. Chin S, Ong T, Chan W, et al. 64 row multi-detector computed tomography coronary image from a centre with early experience: first illustration of learning curve. J Geriatr Cardiol 2006;3:29-34.
    1. Andreini D, Pontone G, Pepi M, et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. J Am Coll Cardiol 2007;49:2044-50. 10.1016/j.jacc.2007.01.086. .
    1. Patel MR, Dai D, Hernandez AF, et alPrevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J 2014;167:846-52.10.1016/j.ahj.2014.03.001.
    1. Patel N, Pal RS, Flores F, Budoff M. Utility of cardiac computed tomography angiography to exclude clinically significant obstructive coronary artery disease in patients after myocardial perfusion imaging. Am J Cardiol 2012;109:165-8. 10.1016/j.amjcard.2011.08.022. .

Source: PubMed

3
Se inscrever